Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

Xin-Ya Shi,Ting-Xiao Shen,Ao-Lin Zhang,Li-Tao Tan,Wen-Chang Shen,Hai-Jiang Zhong,Shun-Lin Zhang,Yu-Lan Gu,Lei Shen

DOI: https://doi.org/10.3389/fchem.2022.1075376

IF: 5.5

2022-11-23

Frontiers in Chemistry

Abstract:[This corrects the article DOI: 10.3389/fchem.2022.856495.].

chemistry, multidisciplinary

What problem does this paper attempt to address?

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
Correction: Engineering Cu 2− x S-conjugated upconverting nanocomposites for NIR-II light-induced enhanced chemodynamic/photothermal therapy of cancer

Kaimin Du,Shuang Zhao,Jing Feng,Xuan Gao,Kai Liu,Xiaozhen Wang,Manli Zhang,Yao Li,Yu Lu,Hongjie Zhang

DOI: https://doi.org/10.1039/d1tb90070f

IF: 7.571

2021-01-01

Journal of Materials Chemistry B

Abstract:Correction for ‘Engineering Cu 2− x S-conjugated upconverting nanocomposites for NIR-II light-induced enhanced chemodynamic/photothermal therapy of cancer’ by Kaimin Du et al. , J. Mater. Chem. B , 2021, DOI: 10.1039/d1tb00337b.

materials science, biomaterials
Corrigendum: HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an in vitro exploration

Matilde Tubertini,Luca Menilli,Celeste Milani,Cecilia Martini,Maria Luisa Navacchia,Marta Nugnes,Manuela Bartolini,Marina Naldi,Daniele Tedesco,Elisa Martella,Andrea Guerrini,Claudia Ferroni,Francesca Moret,Greta Varchi

DOI: https://doi.org/10.3389/fchem.2024.1443822

2024-06-18

Abstract:[This corrects the article DOI: 10.3389/fchem.2024.1378233.].
Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Huaxia Shi,Wucheng Sun,Changbing Liu,Guiying Gu,Bo Ma,Weili Si,Nina Fu,Qi Zhang,Wei Huang,Xiaochen Dong

DOI: https://doi.org/10.1039/d3tb90090h

IF: 7.571

2023-01-01

Journal of Materials Chemistry B

Abstract:Correction for ‘Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy’ by Huaxia Shi et al. , J. Mater. Chem. B , 2016, 4 , 113–120, https://doi.org/10.1039/C5TB02041G.

materials science, biomaterials
Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Yuanyuan Chen,Hui Zhong,Jianbo Wang,Xiuyan Wan,Yanhua Li,Wei Pan,Na Li,Bo Tang

DOI: https://doi.org/10.1039/d0sc90108c

IF: 8.4

2020-01-01

Chemical Science

Abstract:Correction for ‘Catalase-like metal–organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence’ by Yuanyuan Chen et al., Chem. Sci., 2019, 10, 5773–5778, DOI: 10.1039/C9SC00747D.
Rational Design of a Gd(III)–Cu(II) Nanobooster for Chemodynamic Therapy Against Cancer Cells

Xin-Ya Shi,Ting-Xiao Shen,Ao-Lin Zhang,Li-Tao Tan,Wen-Chang Shen,Hai-Jiang Zhong,Shun-Lin Zhang,Yu-Lan Gu,Lei Shen

DOI: https://doi.org/10.3389/fchem.2022.856495

IF: 5.5

2022-04-07

Frontiers in Chemistry

Abstract:Copper (II) containing coordination complexes have attracted much attention for chemodynamic therapy (CDT) against cancer cells. In this study, the bimetallic nanobooster [Gd 2 Cu(L) 2 (H 2 O) 10 ]·6H 2 O was prepared by a solvothermal method based on tetrazole carboxylic acid ligand H 4 L [H 4 L = 3,3-di (1H-tetrazol-5-yl) pentanedioic acid]. It showed considerable cytotoxicity toward three kinds of human cancer cells (HeLa, HepG2, and HT29). The MTT assay showed that the IC 50 (half-maximal inhibitory concentration) of the complex NPs on HeLa cells (4.9 μg/ml) is superior to that of HepG2 (11.1 μg/ml) and HT29 (5.5 μg/ml). This result showed that [Gd 2 Cu(L) 2 (H 2 O) 10 ]·6H 2 O NPs can inhibit cell proliferation in vitro and may be potential candidates for chemodynamic therapy. In addition, the cytotoxicity was also confirmed by the trypan blue staining experiment. The results promise the great potential of Gd(III)–Cu(II) for CDT against cancer cells.

chemistry, multidisciplinary
Correction: A highly X-ray sensitive iridium prodrug for visualized tumor radiochemotherapy

Zhennan Zhao,Pan Gao,Li Ma,Tianfeng Chen

DOI: https://doi.org/10.1039/d1sc90029c

IF: 8.4

2021-01-01

Chemical Science

Abstract:Correction for ’A highly X-ray sensitive iridium prodrug for visualized tumor radiochemotherapy’ by Zhennan Zhao et al. , Chem. Sci. , 2020, 11 , 3780–3789, DOI: 10.1039/D0SC00862A

chemistry, multidisciplinary
Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Qi Chang Zheng,Shuai Jiang,Yu Zhe Wu,Dan Shang,Yong Zhang,Shao Bo Hu,Xiang Cheng,Chen Zhang,Ping Sun,Yang Gao,Zi Fang Song,Min Li

DOI: https://doi.org/10.3389/fbioe.2021.656268

IF: 5.7

2021-02-11

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2020.00512.].

multidisciplinary sciences
Correction: Copper coordination-based conjugated polymer nanoparticles for synergistic photodynamic and chemodynamic therapy

Qiang Cheng,Yuyan Li,Wei Huang,Ke Li,Minhuan Lan,Benhua Wang,Jianxiu Wang,Xiangzhi Song

DOI: https://doi.org/10.1039/d3cc90149a

IF: 4.9

2023-05-12

Chemical Communications

Abstract:Correction for 'Copper coordination-based conjugated polymer nanoparticles for synergistic photodynamic and chemodynamic therapy' by Qiang Cheng et al. , Chem. Commun. , 2023, https://doi.org/10.1039/d3cc01107k.

chemistry, multidisciplinary
Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles"

Kin Man Au,Rod Balhorn,Monique C Balhorn,Steven I Park,Andrew Z Wang

DOI: https://doi.org/10.1021/acscentsci.4c00703

2024-05-08

Abstract:[This corrects the article DOI: 10.1021/acscentsci.8b00746.].
Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Zhilin Li,Hao Cai,Zhiqian Li,Long Ren,Xuelei Ma,Hongyan Zhu,Qiyong Gong,Hu Zhang,Zhongwei Gu,Kui Luo

DOI: https://doi.org/10.1016/j.bioactmat.2022.09.016

IF: 18.9

2023-04-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.028.].

engineering, biomedical,materials science, biomaterials
Correction to "Nanoscale Coordination Polymers for Combined Chemotherapy and Photodynamic Therapy of Metastatic Cancer"

Youyou Li,Wenbo Han,Chunbai He,Xiaomin Jiang,Yingjie Fan,Wenbin Lin

DOI: https://doi.org/10.1021/acs.bioconjchem.4c00455

IF: 4.7

2024-10-26

Bioconjugate Chemistry

Abstract:Bioconjug Chem . 2024 Oct 25. doi: 10.1021/acs.bioconjchem.4c00455. Online ahead of print. NO

chemistry, multidisciplinary,biochemistry & molecular biology, organic,biochemical research methods
Corrigendum to "Emulsifying Lipiodol with pH-Sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis" Mater. Today Bio, 23, 2023, 100873, ISSN 2590-0064

Qing Shi,Xingxing Zhang,Minmin Wu,Yuhan Xia,Yating Pan,Jialu Weng,Na Li,Xingjie Zan,Jinglin Xia

DOI: https://doi.org/10.1016/j.mtbio.2023.100916

2023-12-26

Abstract:[This corrects the article DOI: 10.1016/j.mtbio.2023.100873.].
Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Wei Wang,Bo Hu,Jiang-Jiang Qin,Jianwen Cheng,Xin Li,Mehrdad Rajaei,Jia Fan,Xin-Rong Yang,Ruiwen Zhang

DOI: https://doi.org/10.1016/j.gendis.2019.12.006

IF: 7.376

2019-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2019.06.001.].
Corrigendum to “Transferrin-Guided Intelligent Nanovesicles Augment the Targetability and Potency of Clinical PLK1 Inhibitor to Acute Myeloid Leukemia” [bioact. Mater. 21 (march 2023) 499–510]

Yifeng Xia,Jingnan An,Jiaying Li,Wenxing Gu,Yifan Zhang,Songsong Zhao,Cenzhu Zhao,Yang Xu,Bin Li,Zhiyuan Zhong,Fenghua Meng

DOI: https://doi.org/10.1016/j.bioactmat.2023.08.011

IF: 18.9

2024-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.032.].
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

Qiuqiang Chen,Gang Jia,Xilin Zhang,Wenxue Ma

DOI: https://doi.org/10.3389/fimmu.2024.1376045

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1332057.].

immunology
Tumor Theranostics of Transition Metal Ions Loaded Polyaminopyrrole Nanoparticles: Erratum

Shuyao Li,Shuwei Liu,Lu Wang,Min Lin,Rui Ge,Xing Li,Xue Zhang,Yi Liu,Lening Zhang,Hongchen Sun,Hao Zhang,Bai Yang

DOI: https://doi.org/10.7150/ntno.67620

2022-01-01

Nanotheranostics

Abstract:[This corrects the article DOI: 10.7150/ntno.25119.].
Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Zekun Li,Yongchun Pan,Shiyu Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qin Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Correction: an Oxygen Self-Sufficient NIR-responsive Nanosystem for Enhanced PDT and Chemotherapy Against Hypoxic Tumors

Guoliang Yang,Jia Tian,Chao Chen,Dawei Jiang,Yudong Xue,Chaochao Wang,Yun Yi Gao,Weian Zhang

DOI: https://doi.org/10.1039/d0sc90197k

IF: 8.4

2020-01-01

Chemical Science

Abstract:Correction for ‘An oxygen self-sufficient NIR-responsive nanosystem for enhanced PDT and chemotherapy against hypoxic tumors’ by Guoliang Yang et al., Chem. Sci., 2019, 10, 5766–5772, DOI: 10.1039/C9SC00985J.

Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Correction: Engineering Cu 2− x S-conjugated upconverting nanocomposites for NIR-II light-induced enhanced chemodynamic/photothermal therapy of cancer

Corrigendum: HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an in vitro exploration

Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Rational Design of a Gd(III)–Cu(II) Nanobooster for Chemodynamic Therapy Against Cancer Cells

Correction: A highly X-ray sensitive iridium prodrug for visualized tumor radiochemotherapy

Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Correction: Copper coordination-based conjugated polymer nanoparticles for synergistic photodynamic and chemodynamic therapy

Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles"

Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Correction to "Nanoscale Coordination Polymers for Combined Chemotherapy and Photodynamic Therapy of Metastatic Cancer"

Corrigendum to "Emulsifying Lipiodol with pH-Sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis" Mater. Today Bio, 23, 2023, 100873, ISSN 2590-0064

Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Corrigendum to “Transferrin-Guided Intelligent Nanovesicles Augment the Targetability and Potency of Clinical PLK1 Inhibitor to Acute Myeloid Leukemia” [bioact. Mater. 21 (march 2023) 499–510]

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

Tumor Theranostics of Transition Metal Ions Loaded Polyaminopyrrole Nanoparticles: Erratum

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Correction: an Oxygen Self-Sufficient NIR-responsive Nanosystem for Enhanced PDT and Chemotherapy Against Hypoxic Tumors